Nature Medicine, Published online: 16 July 2025; doi:10.1038/s41591-025-03781-wIn this multicenter phase 1 trial, patients with advanced gastric and gastroesophageal junction
Nature Medicine, Published online: 15 July 2025; doi:10.1038/s41591-025-03807-3A new Global Neurodegeneration Proteomics Consortium provides a wealth of data to boost
It’s easy to bat away common symptoms like headaches, nausea and fevers on a day-to-day basis, but they might be
Popular weight loss medications could significantly reduce the risk of dementia and stroke in people living with type 2 diabetes
Britons are severely sleep deprived, leaving millions vulnerable to various health complications. As the search for effective sleep solutions leads
A drug has been developed that could transform stroke treatment by extending the critical intervention window from three to six
A Surrey hospital trust has become the first in England to introduce a revolutionary DIY heart monitoring system aimed at
The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin [DBV712] Peanut Patch), Novartis (Remibrutinib),
This investment has also been exempted from the 30% net worth ceiling stipulated by the Department of Public Enterprises (DPE)
The revised delegation enhances NTPC’s earlier approved investment ceiling of ₹7,500 crore, and is aimed at enabling the company to
